In mice, NHPs, and humans the first dose of therapeutic anti-CD47 antibodies results in a dose-dependent anemia that we interpret as due to saturation of RBC CD4711,64 plus an “eat me” signal such as CRT, made by sinusoidal macrophages. This evidence concerns the gene CALR and anemia (phenotype).